Company Filing History:
Years Active: 1992-2003
Title: Gary A. Anderson: Innovator in Veterinary Vaccines
Introduction
Gary A. Anderson is a notable inventor based in Bucyrus, Kansas, known for his contributions to veterinary medicine through innovative vaccine development. With a total of 2 patents, Anderson has made significant strides in preventing bacterial infections in animals.
Latest Patents
Anderson's latest patents include a vaccine for Fusobacterium necrophorum and a method for producing such a vaccine. This invention focuses on isolating the bacteria from bovine species and growing it in a suitable medium to achieve a specific bacterial population. The method culminates in creating a vaccine from a killed whole cell culture of the bacteria, aimed at preventing footrot and liver abscesses. Another significant patent involves using human interleukin-2 (IL-2) as a vaccine adjuvant, enhancing the immune response in animals post-vaccination.
Career Highlights
Throughout his career, Anderson has worked with prominent companies in the field, including Cetus Corporation and Novartis Animal Health, Inc. His work has been pivotal in advancing veterinary vaccine technology, contributing to better health outcomes for livestock.
Collaborations
Anderson has collaborated with notable colleagues such as Michael V. Doyle and Arthur D. Newell, further enriching his research and development efforts in the field of veterinary medicine.
Conclusion
Gary A. Anderson's innovative work in vaccine development has made a lasting impact on veterinary medicine, showcasing his dedication to improving animal health through scientific advancements.